@infotraddr-com
-
actplatform and
Alex Popovych are now friends 9 years, 7 months ago
-
actplatform and
sanyi77 are now friends 9 years, 7 months ago
-
sanyi77 commented on the post, Scientist Discovered Why Most Traders Lose Money – 24 Surprising Statistics 9 years, 8 months ago
Yea same here
-
actplatform commented on the post, Scientist Discovered Why Most Traders Lose Money – 24 Surprising Statistics 9 years, 8 months ago
#5 pretty much says it for what we do at http://www.actplatform.trade That is cultivating long-term traders.
-
sanyi77 wrote a new post 9 years, 8 months ago
Jason Trennert, Strategas Research, and Phil Orlando, Federated, provide their outlook on the markets after the Fed hikes interest rates.
-
actplatform posted an update 9 years, 8 months ago
Fed to dominate week of central bank meetings
http://finance.yahoo.com/news/fed-dominate-week-central-bank-091806552.html -
sanyi77 and
Traddr are now friends 9 years, 8 months ago
-
sanyi77 wrote a new post 9 years, 8 months ago
This is Part 1 in educational series from James Altucher. A hedge fund insider who Blows the Whistle on the Greatest Scam Ever Sold!
There’s a saying in poker: “If you can’t spot the sucker at the table,
-
sanyi77 wrote a new post 9 years, 8 months ago
By NICOLE HONG
Stock traders might want to start paying a bit more attention to the Supreme Court.
That’s according to one research report published this week that says Supreme Court decisions moved the
-
actplatform commented on the post, $TTPH Tetraphase Announces Top-Line Results From IGNITE2 Phase 3 9 years, 8 months ago
$TTPH CEO dumped huge amount just the other day: https://www.sec.gov/Archives/edgar/data/1296998/000120919115069484/xslF345X03/doc4.xml
-
sanyi77 wrote a new post 9 years, 8 months ago
WATERTOWN, Mass., Sept. 8, 2015 (GLOBE NEWSWIRE) — Tetraphase Pharmaceuticals, Inc.(TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant
-
sanyi77 wrote a new post 9 years, 8 months ago
VANCOUVER, British Columbia, Sept. 8, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease
-
sanyi77 joined the group
Pro traders 9 years, 8 months ago
-
actplatform changed their profile picture 9 years, 8 months ago
-
actplatform changed their profile picture 9 years, 8 months ago
-
sanyi77 changed their profile picture 9 years, 8 months ago
-
sanyi77 started the topic
Why is $AXPW moving higher? in the forum Stock market club 9 years, 8 months ago
why?
-
sanyi77 joined the group
Stock market club 9 years, 8 months ago